Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

NCT02472717 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Psoriatic Arthritis
Psoriasis
Impaired Glucose Tolerance
Type 2 Diabetes

Interventions

DRUG: liraglutide
OTHER: Placebo

Sponsor

University Health Network, Toronto

Collaborators

[object Object]